Literature DB >> 3012969

Thymidine kinase in extracts of human brain tumours.

L Persson, S J Gronowitz, C F Källander.   

Abstract

Deoxythymidine kinase (TK) is an enzyme involved in DNA synthesis. It can be used as a marker of cell proliferation. TK was measured in extracts of human brain tumours and non-neoplastic brain tissue. In astrocytomas the mean TK activity increased with increasing grade of malignancy. Oligodendrogliomas showed higher TK activity than astrocytomas. The highest activities were noted in menigiomas, of which the recurrent ones exceeded the primary in TK activity. In non-neoplastic brain tissue lower TK activity was found. It is concluded that TK can be measured in human brain tumour extracts, and is potentially of use for studies on tumour cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012969     DOI: 10.1007/bf01812286

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  9 in total

1.  Induction of thymidine kinases in phytohaemagglutinin-stimulated human lymphocytes.

Authors:  B Munch-Petersen; G Tyrsted
Journal:  Biochim Biophys Acta       Date:  1977-10-04

2.  Regulation of thymidine kinase synthesis in human cells.

Authors:  L J Bello
Journal:  Exp Cell Res       Date:  1974-12       Impact factor: 3.905

3.  Histological subtypes and prognostic problems in meningiomas.

Authors:  K Jellinger; F Slowik
Journal:  J Neurol       Date:  1975       Impact factor: 4.849

4.  Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors.

Authors:  A Russo; L Gianni; T J Kinsella; R W Klecker; J Jenkins; J Rowland; E Glatstein; J B Mitchell; J Collins; C Myers
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

5.  Application of an in vitro assay for serum thymidine kinase: results on viral disease and malignancies in humans.

Authors:  J S Gronowitz; F R Källander; H Diderholm; H Hagberg; U Pettersson
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

6.  Deoxythymidine-kinase in cerebrospinal fluid: a new potential "marker" for brain tumours.

Authors:  J S Gronowitz; C F Källander; H Hagberg; L Persson
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

Review 7.  Are there unexploited possibilities for the therapeutic use of radioactive and stable isotopically labeled DNA precursors and extracorporeal irradiation of the blood in treatment of leukemia?

Authors:  E P Cronkite; R G Fairchild; M E Miller
Journal:  Blood Cells       Date:  1983

8.  Thymidine kinase in brain-tumor cysts.

Authors:  L Persson; J Boethius; J S Gronowitz; C Källander; L Lindgren
Journal:  J Neurosurg       Date:  1985-10       Impact factor: 5.115

9.  Genetics of human cell lines. III. Incorporation of 5-bromo- and 5-iododeoxyuridine into the deoxyribonucleic acid of human cells and its effect on radiation sensitivity.

Authors:  B DJORDJEVIC; W SZYBALSKI
Journal:  J Exp Med       Date:  1960-09-01       Impact factor: 14.307

  9 in total
  5 in total

Review 1.  Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications.

Authors:  M Hallek; L Wanders; S Strohmeyer; B Emmerich
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

2.  Neuron specific enolase (NSE) and thymidine kinase (TK) as markers in biological fluids of brain tumor patients.

Authors:  A Boiardi; L Munari; A Silvani; C L Solero; E Bombardieri
Journal:  Ital J Neurol Sci       Date:  1990-08

3.  Incidental Detection of Meningioma by 18F-FMAU PET/CT in a Patient With Suspected Prostate Cancer.

Authors:  Bino Varghese; Erik Velez; Bhushan Desai; Hossein Jadvar
Journal:  Clin Nucl Med       Date:  2018-07       Impact factor: 7.794

4.  Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.

Authors:  M Hallek; B Emmerich; S Strohmeyer; R Busch; A Reichle; R Senekowitsch
Journal:  Klin Wochenschr       Date:  1988-08-15

5.  A sequential cell kinetic study of meningioma cells in primary explant culture using bromodeoxyuridine.

Authors:  K Kharbanda; A K Karak; C Sarkar; A K Dinda; M Mathur; S Roy
Journal:  J Neurooncol       Date:  1993-05       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.